3-[(1-acetylpiperidin-4-yl)methyl]-2-amino-5-[3-(3,5-dichlorophenyl)phenyl]-5-methylimidazol-4-one;(6S)-2-amino-6-(1-benzothiophen-5-yl)-3,6-dimethyl-5H-pyrimidin-4-one;N-[(1R,3S)-3-[[(4R)-2-amino-4-(2-cyclohexylethyl)-1-methyl-5-oxoimidazol-4-yl]methyl]cyclohexyl]-2-chloropyridine-4-carboxamide;N-[(1R,3S)-3-[[(4R)-2-amino-4-(2-cyclohexylethyl)-1-methyl-5-oxoimidazol-4-yl]methyl]cyclohexyl]-1-phenylmethanesulfonamide;2-amino-5-cyclopropyl-5-[3-(3,5-dichlorophenyl)phenyl]-3-methylimidazolidin-4-one

C108H136Cl5N19O9S2 — CID 158209963

IUPAC3-[(1-acetylpiperidin-4-yl)methyl]-2-amino-5-[3-(3,5-dichlorophenyl)phenyl]-5-methylimidazol-4-one;(6S)-2-amino-6-(1-benzothiophen-5-yl)-3,6-dimethyl-5H-pyrimidin-4-one;N-[(1R,3S)-3-[[(4R)-2-amino-4-(2-cyclohexylethyl)-1-methyl-5-oxoimidazol-4-yl]methyl]cyclohexyl]-2-chloropyridine-4-carboxamide;N-[(1R,3S)-3-[[(4R)-2-amino-4-(2-cyclohexylethyl)-1-methyl-5-oxoimidazol-4-yl]methyl]cyclohexyl]-1-phenylmethanesulfonamide;2-amino-5-cyclopropyl-5-[3-(3,5-dichlorophenyl)phenyl]-3-methylimidazolidin-4-one
SMILESCC(=O)N1CCC(CN2C(=O)C(C)(c3cccc(-c4cc(Cl)cc(Cl)c4)c3)N=C2N)CC1.CN1C(=O)C(c2cccc(-c3cc(Cl)cc(Cl)c3)c2)(C2CC2)NC1N.CN1C(=O)C[C@@](C)(c2ccc3sccc3c2)N=C1N.CN1C(=O)[C@@](CCC2CCCCC2)(C[C@H]2CCC[C@@H](NC(=O)c3ccnc(Cl)c3)C2)N=C1N.CN1C(=O)[C@@](CCC2CCCCC2)(C[C@H]2CCC[C@@H](NS(=O)(=O)Cc3ccccc3)C2)N=C1N
InChIInChI=1S/C26H40N4O3S.C25H36ClN5O2.C24H26Cl2N4O2.C19H19Cl2N3O.C14H15N3OS/c1-30-24(31)26(28-25(30)27,16-15-20-9-4-2-5-10-20)18-22-13-8-14-23(17-22)29-34(32,33)19-21-11-6-3-7-12-21;1-31-23(33)25(30-24(31)27,12-10-17-6-3-2-4-7-17)16-18-8-5-9-20(14-18)29-22(32)19-11-13-28-21(26)15-19;1-15(31)29-8-6-16(7-9-29)14-30-22(32)24(2,28-23(30)27)19-5-3-4-17(10-19)18-11-20(25)13-21(26)12-18;1-24-17(25)19(13-5-6-13,23-18(24)22)14-4-2-3-11(7-14)12-8-15(20)10-16(21)9-12;1-14(8-12(18)17(2)13(15)16-14)10-3-4-11-9(7-10)5-6-19-11/h3,6-7,11-12,20,22-23,29H,2,4-5,8-10,13-19H2,1H3,(H2,27,28);11,13,15,17-18,20H,2-10,12,14,16H2,1H3,(H2,27,30)(H,29,32);3-5,10-13,16H,6-9,14H2,1-2H3,(H2,27,28);2-4,7-10,13,18,23H,5-6,22H2,1H3;3-7H,8H2,1-2H3,(H2,15,16)/t22-,23+,26+;18-,20+,25+;;;14-/m00..0/s1
InChIKeyGBYLSCZBDXVCGI-GOSHVCBVSA-N
MW2085.80 g/mol
LogP18.39
Rot. Bonds24

About 3-[(1-acetylpiperidin-4-yl)methyl]-2-amino-5-[3-(3,5-dichlorophenyl)phenyl]-5-methylimidazol-4-one;(6S)-2-amino-6-(1-benzothiophen-5-yl)-3,6-dimethyl-5H-pyrimidin-4-one;N-[(1R,3S)-3-[[(4R)-2-amino-4-(2-cyclohexylethyl)-1-methyl-5-oxoimidazol-4-yl]methyl]cyclohexyl]-2-chloropyridine-4-carboxamide;N-[(1R,3S)-3-[[(4R)-2-amino-4-(2-cyclohexylethyl)-1-methyl-5-oxoimidazol-4-yl]methyl]cyclohexyl]-1-phenylmethanesulfonamide;2-amino-5-cyclopropyl-5-[3-(3,5-dichlorophenyl)phenyl]-3-methylimidazolidin-4-one

3-[(1-acetylpiperidin-4-yl)methyl]-2-amino-5-[3-(3,5-dichlorophenyl)phenyl]-5-methylimidazol-4-one;(6S)-2-amino-6-(1-benzothiophen-5-yl)-3,6-dimethyl-5H-pyrimidin-4-one;N-[(1R,3S)-3-[[(4R)-2-amino-4-(2-cyclohexylethyl)-1-methyl-5-oxoimidazol-4-yl]methyl]cyclohexyl]-2-chloropyridine-4-carboxamide;N-[(1R,3S)-3-[[(4R)-2-amino-4-(2-cyclohexylethyl)-1-methyl-5-oxoimidazol-4-yl]methyl]cyclohexyl]-1-phenylmethanesulfonamide;2-amino-5-cyclopropyl-5-[3-(3,5-dichlorophenyl)phenyl]-3-methylimidazolidin-4-one (PubChem CID 158209963) has the molecular formula C108H136Cl5N19O9S2 and a molecular weight of 2085.80 g/mol. Its IUPAC name is 3-[(1-acetylpiperidin-4-yl)methyl]-2-amino-5-[3-(3,5-dichlorophenyl)phenyl]-5-methylimidazol-4-one;(6S)-2-amino-6-(1-benzothiophen-5-yl)-3,6-dimethyl-5H-pyrimidin-4-one;N-[(1R,3S)-3-[[(4R)-2-amino-4-(2-cyclohexylethyl)-1-methyl-5-oxoimidazol-4-yl]methyl]cyclohexyl]-2-chloropyridine-4-carboxamide;N-[(1R,3S)-3-[[(4R)-2-amino-4-(2-cyclohexylethyl)-1-methyl-5-oxoimidazol-4-yl]methyl]cyclohexyl]-1-phenylmethanesulfonamide;2-amino-5-cyclopropyl-5-[3-(3,5-dichlorophenyl)phenyl]-3-methylimidazolidin-4-one.

Molecular Properties

Compound Name3-[(1-acetylpiperidin-4-yl)methyl]-2-amino-5-[3-(3,5-dichlorophenyl)phenyl]-5-methylimidazol-4-one;(6S)-2-amino-6-(1-benzothiophen-5-yl)-3,6-dimethyl-5H-pyrimidin-4-one;N-[(1R,3S)-3-[[(4R)-2-amino-4-(2-cyclohexylethyl)-1-methyl-5-oxoimidazol-4-yl]methyl]cyclohexyl]-2-chloropyridine-4-carboxamide;N-[(1R,3S)-3-[[(4R)-2-amino-4-(2-cyclohexylethyl)-1-methyl-5-oxoimidazol-4-yl]methyl]cyclohexyl]-1-phenylmethanesulfonamide;2-amino-5-cyclopropyl-5-[3-(3,5-dichlorophenyl)phenyl]-3-methylimidazolidin-4-one
PubChem CID158209963
Molecular FormulaC108H136Cl5N19O9S2
Molecular Weight2085.80 g/mol
Exact Mass2081.87
IUPAC Name3-[(1-acetylpiperidin-4-yl)methyl]-2-amino-5-[3-(3,5-dichlorophenyl)phenyl]-5-methylimidazol-4-one;(6S)-2-amino-6-(1-benzothiophen-5-yl)-3,6-dimethyl-5H-pyrimidin-4-one;N-[(1R,3S)-3-[[(4R)-2-amino-4-(2-cyclohexylethyl)-1-methyl-5-oxoimidazol-4-yl]methyl]cyclohexyl]-2-chloropyridine-4-carboxamide;N-[(1R,3S)-3-[[(4R)-2-amino-4-(2-cyclohexylethyl)-1-methyl-5-oxoimidazol-4-yl]methyl]cyclohexyl]-1-phenylmethanesulfonamide;2-amino-5-cyclopropyl-5-[3-(3,5-dichlorophenyl)phenyl]-3-methylimidazolidin-4-one
SMILESCC(=O)N1CCC(CN2C(=O)C(C)(c3cccc(-c4cc(Cl)cc(Cl)c4)c3)N=C2N)CC1.CN1C(=O)C(c2cccc(-c3cc(Cl)cc(Cl)c3)c2)(C2CC2)NC1N.CN1C(=O)C[C@@](C)(c2ccc3sccc3c2)N=C1N.CN1C(=O)[C@@](CCC2CCCCC2)(C[C@H]2CCC[C@@H](NC(=O)c3ccnc(Cl)c3)C2)N=C1N.CN1C(=O)[C@@](CCC2CCCCC2)(C[C@H]2CCC[C@@H](NS(=O)(=O)Cc3ccccc3)C2)N=C1N
InChIInChI=1S/C26H40N4O3S.C25H36ClN5O2.C24H26Cl2N4O2.C19H19Cl2N3O.C14H15N3OS/c1-30-24(31)26(28-25(30)27,16-15-20-9-4-2-5-10-20)18-22-13-8-14-23(17-22)29-34(32,33)19-21-11-6-3-7-12-21;1-31-23(33)25(30-24(31)27,12-10-17-6-3-2-4-7-17)16-18-8-5-9-20(14-18)29-22(32)19-11-13-28-21(26)15-19;1-15(31)29-8-6-16(7-9-29)14-30-22(32)24(2,28-23(30)27)19-5-3-4-17(10-19)18-11-20(25)13-21(26)12-18;1-24-17(25)19(13-5-6-13,23-18(24)22)14-4-2-3-11(7-14)12-8-15(20)10-16(21)9-12;1-14(8-12(18)17(2)13(15)16-14)10-3-4-11-9(7-10)5-6-19-11/h3,6-7,11-12,20,22-23,29H,2,4-5,8-10,13-19H2,1H3,(H2,27,28);11,13,15,17-18,20H,2-10,12,14,16H2,1H3,(H2,27,30)(H,29,32);3-5,10-13,16H,6-9,14H2,1-2H3,(H2,27,28);2-4,7-10,13,18,23H,5-6,22H2,1H3;3-7H,8H2,1-2H3,(H2,15,16)/t22-,23+,26+;18-,20+,25+;;;14-/m00..0/s1
InChIKeyGBYLSCZBDXVCGI-GOSHVCBVSA-N
XLogP18.39
TPSA401.59 Ų
H-Bond Donors8
H-Bond Acceptors21
Rotatable Bonds24
Heavy Atoms143
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002085.80
LogP ≤ 518.39
H-Bond Donors ≤ 58
H-Bond Acceptors ≤ 1021

Computed Properties (RDKit)

Structural Alerts{'alert_name': '2-halo_pyridine', 'substructure': 'N/A'}

Analyze 3-[(1-acetylpiperidin-4-yl)methyl]-2-amino-5-[3-(3,5-dichlorophenyl)phenyl]-5-methylimidazol-4-one;(6S)-2-amino-6-(1-benzothiophen-5-yl)-3,6-dimethyl-5H-pyrimidin-4-one;N-[(1R,3S)-3-[[(4R)-2-amino-4-(2-cyclohexylethyl)-1-methyl-5-oxoimidazol-4-yl]methyl]cyclohexyl]-2-chloropyridine-4-carboxamide;N-[(1R,3S)-3-[[(4R)-2-amino-4-(2-cyclohexylethyl)-1-methyl-5-oxoimidazol-4-yl]methyl]cyclohexyl]-1-phenylmethanesulfonamide;2-amino-5-cyclopropyl-5-[3-(3,5-dichlorophenyl)phenyl]-3-methylimidazolidin-4-one with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

2-amino-3-[7-(4-chlorophenyl)-6-oxoheptyl]-5,5-diphenylimidazol-4-one;2-amino-5-[3-(3-chlorophenyl)phenyl]-3-[[(3S)-1-(2-cyclohexylacetyl)pyrrolidin-3-yl]methyl]-5-methylimidazol-4-one;1-[(1S,3S)-3-[[(4R)-2-amino-1,4-dimethyl-5-oxoimidazol-4-yl]methyl]cyclohexyl]-3-phenylurea;N-[(1R,3S)-3-[[(4R)-2-amino-1-methyl-5-oxo-4-(2-phenylethyl)imidazol-4-yl]methyl]cyclohexyl]pyridine-4-carboxamide;N-[4-[(2-amino-5-oxo-4,4-diphenylimidazol-1-yl)methyl]phenyl]thiophene-2-sulfonamide
CID 157642429
(6S)-2-amino-6-(1-benzothiophen-5-yl)-6-methyl-3-(pyridin-4-ylmethyl)-5H-pyrimidin-4-one;2-amino-5-[3-(3-chlorophenyl)phenyl]-3-cyclopentyl-5-cyclopropylimidazol-4-one;(5R)-2-amino-5-cyclopropyl-5-[3-(2-fluoro-3-pyridinyl)phenyl]-3-methylimidazol-4-one;3-[(4S,5S)-2-amino-1,4-dimethyl-5-[4-(2-methyl-5-oxopyrrolidin-1-yl)phenyl]-6-oxo-5H-pyrimidin-4-yl]benzonitrile;3-[(4S,5R)-2-amino-1,4-dimethyl-5-[4-(2-methyl-5-oxopyrrolidin-1-yl)phenyl]-6-oxo-5H-pyrimidin-4-yl]benzonitrile;5-[5-[(4S)-2-amino-1,4-dimethyl-6-oxo-5-phenylsulfanyl-5H-pyrimidin-4-yl]thiophen-3-yl]pyridine-3-carbonitrile;1-[4-(2-amino-5-oxo-4,4-diphenylimidazol-1-yl)butyl]-3-ethylurea
CID 158556948
3-[(1-acetylpiperidin-4-yl)methyl]-2-amino-5-[3-(1H-indol-4-yl)phenyl]-5-methylimidazol-4-one;2-amino-3-[(4-chlorophenyl)methyl]-5,5-diphenylimidazol-4-one;2-amino-3-methyl-5-phenyl-5-(4-pyridin-3-ylthiophen-2-yl)imidazol-4-one;N-[3-[(2-amino-5-oxo-4,4-diphenylimidazol-1-yl)methyl]phenyl]cyclopropanesulfonamide;3-[(2-amino-5-oxo-4,4-diphenylimidazol-1-yl)methyl]-N-(pyridin-2-ylmethyl)benzamide
CID 158563961
3-[[3-(4-acetylpiperazine-1-carbonyl)phenyl]methyl]-2-amino-5,5-diphenylimidazol-4-one;2-amino-5-[3-(3-chlorophenyl)phenyl]-3-[[(3S)-1-cyclohexylpyrrolidin-3-yl]methyl]-5-methylimidazol-4-one;2-amino-3-[2-(dimethylamino)ethyl]-5,5-diphenylimidazol-4-one;(6S)-2-amino-3,6-dimethyl-6-(4-thiophen-2-yl-2-pyridinyl)-5H-pyrimidin-4-one;2-amino-3-methyl-5-[5-(3-methylsulfanylphenyl)thiophen-2-yl]-5-phenylimidazol-4-one;1-[4-(2-amino-5-oxo-4,4-diphenylimidazol-1-yl)butyl]-3-(4-fluorophenyl)urea
CID 159280437
(6S)-2-amino-6-(1-benzothiophen-5-yl)-6-methyl-3-(2-piperidin-1-ylethyl)-5H-pyrimidin-4-one;2-amino-3-[(2,4-dichlorophenyl)methyl]-5,5-diphenylimidazol-4-one;N-[[2-[3-(2-amino-1,4-dimethyl-5-oxoimidazol-4-yl)phenyl]-4-chlorophenyl]methyl]pyridine-4-carboxamide;3-[(4S,5S)-2-amino-1,4-dimethyl-6-oxo-5-[4-(2-oxo-4-phenylpyrrolidin-1-yl)phenyl]-5H-pyrimidin-4-yl]benzonitrile;2-amino-3-methyl-5-phenyl-5-[3-(pyridin-3-ylmethylamino)phenyl]imidazol-4-one
CID 159372048
2-amino-5-[3-(3-chlorophenyl)phenyl]-5-cyclopropyl-3-(thiophen-2-ylmethyl)imidazol-4-one;N-[(1R,3S)-3-[[(4R)-2-amino-4-(2-cyclohexylethyl)-1-methyl-5-oxoimidazol-4-yl]methyl]cyclohexyl]-6-fluoropyridine-3-carboxamide;2-amino-5-cyclopropyl-3-methyl-5-[3-(5-methyl-3-pyridinyl)phenyl]imidazol-4-one
CID 159478898

Frequently Asked Questions

What is the IUPAC name of 3-[(1-acetylpiperidin-4-yl)methyl]-2-amino-5-[3-(3,5-dichlorophenyl)phenyl]-5-methylimidazol-4-one;(6S)-2-amino-6-(1-benzothiophen-5-yl)-3,6-dimethyl-5H-pyrimidin-4-one;N-[(1R,3S)-3-[[(4R)-2-amino-4-(2-cyclohexylethyl)-1-methyl-5-oxoimidazol-4-yl]methyl]cyclohexyl]-2-chloropyridine-4-carboxamide;N-[(1R,3S)-3-[[(4R)-2-amino-4-(2-cyclohexylethyl)-1-methyl-5-oxoimidazol-4-yl]methyl]cyclohexyl]-1-phenylmethanesulfonamide;2-amino-5-cyclopropyl-5-[3-(3,5-dichlorophenyl)phenyl]-3-methylimidazolidin-4-one?
The IUPAC name of 3-[(1-acetylpiperidin-4-yl)methyl]-2-amino-5-[3-(3,5-dichlorophenyl)phenyl]-5-methylimidazol-4-one;(6S)-2-amino-6-(1-benzothiophen-5-yl)-3,6-dimethyl-5H-pyrimidin-4-one;N-[(1R,3S)-3-[[(4R)-2-amino-4-(2-cyclohexylethyl)-1-methyl-5-oxoimidazol-4-yl]methyl]cyclohexyl]-2-chloropyridine-4-carboxamide;N-[(1R,3S)-3-[[(4R)-2-amino-4-(2-cyclohexylethyl)-1-methyl-5-oxoimidazol-4-yl]methyl]cyclohexyl]-1-phenylmethanesulfonamide;2-amino-5-cyclopropyl-5-[3-(3,5-dichlorophenyl)phenyl]-3-methylimidazolidin-4-one (CID 158209963) is 3-[(1-acetylpiperidin-4-yl)methyl]-2-amino-5-[3-(3,5-dichlorophenyl)phenyl]-5-methylimidazol-4-one;(6S)-2-amino-6-(1-benzothiophen-5-yl)-3,6-dimethyl-5H-pyrimidin-4-one;N-[(1R,3S)-3-[[(4R)-2-amino-4-(2-cyclohexylethyl)-1-methyl-5-oxoimidazol-4-yl]methyl]cyclohexyl]-2-chloropyridine-4-carboxamide;N-[(1R,3S)-3-[[(4R)-2-amino-4-(2-cyclohexylethyl)-1-methyl-5-oxoimidazol-4-yl]methyl]cyclohexyl]-1-phenylmethanesulfonamide;2-amino-5-cyclopropyl-5-[3-(3,5-dichlorophenyl)phenyl]-3-methylimidazolidin-4-one.
What is the SMILES notation for 3-[(1-acetylpiperidin-4-yl)methyl]-2-amino-5-[3-(3,5-dichlorophenyl)phenyl]-5-methylimidazol-4-one;(6S)-2-amino-6-(1-benzothiophen-5-yl)-3,6-dimethyl-5H-pyrimidin-4-one;N-[(1R,3S)-3-[[(4R)-2-amino-4-(2-cyclohexylethyl)-1-methyl-5-oxoimidazol-4-yl]methyl]cyclohexyl]-2-chloropyridine-4-carboxamide;N-[(1R,3S)-3-[[(4R)-2-amino-4-(2-cyclohexylethyl)-1-methyl-5-oxoimidazol-4-yl]methyl]cyclohexyl]-1-phenylmethanesulfonamide;2-amino-5-cyclopropyl-5-[3-(3,5-dichlorophenyl)phenyl]-3-methylimidazolidin-4-one?
The canonical SMILES for 3-[(1-acetylpiperidin-4-yl)methyl]-2-amino-5-[3-(3,5-dichlorophenyl)phenyl]-5-methylimidazol-4-one;(6S)-2-amino-6-(1-benzothiophen-5-yl)-3,6-dimethyl-5H-pyrimidin-4-one;N-[(1R,3S)-3-[[(4R)-2-amino-4-(2-cyclohexylethyl)-1-methyl-5-oxoimidazol-4-yl]methyl]cyclohexyl]-2-chloropyridine-4-carboxamide;N-[(1R,3S)-3-[[(4R)-2-amino-4-(2-cyclohexylethyl)-1-methyl-5-oxoimidazol-4-yl]methyl]cyclohexyl]-1-phenylmethanesulfonamide;2-amino-5-cyclopropyl-5-[3-(3,5-dichlorophenyl)phenyl]-3-methylimidazolidin-4-one is CC(=O)N1CCC(CN2C(=O)C(C)(c3cccc(-c4cc(Cl)cc(Cl)c4)c3)N=C2N)CC1.CN1C(=O)C(c2cccc(-c3cc(Cl)cc(Cl)c3)c2)(C2CC2)NC1N.CN1C(=O)C[C@@](C)(c2ccc3sccc3c2)N=C1N.CN1C(=O)[C@@](CCC2CCCCC2)(C[C@H]2CCC[C@@H](NC(=O)c3ccnc(Cl)c3)C2)N=C1N.CN1C(=O)[C@@](CCC2CCCCC2)(C[C@H]2CCC[C@@H](NS(=O)(=O)Cc3ccccc3)C2)N=C1N.
What is the InChIKey of 3-[(1-acetylpiperidin-4-yl)methyl]-2-amino-5-[3-(3,5-dichlorophenyl)phenyl]-5-methylimidazol-4-one;(6S)-2-amino-6-(1-benzothiophen-5-yl)-3,6-dimethyl-5H-pyrimidin-4-one;N-[(1R,3S)-3-[[(4R)-2-amino-4-(2-cyclohexylethyl)-1-methyl-5-oxoimidazol-4-yl]methyl]cyclohexyl]-2-chloropyridine-4-carboxamide;N-[(1R,3S)-3-[[(4R)-2-amino-4-(2-cyclohexylethyl)-1-methyl-5-oxoimidazol-4-yl]methyl]cyclohexyl]-1-phenylmethanesulfonamide;2-amino-5-cyclopropyl-5-[3-(3,5-dichlorophenyl)phenyl]-3-methylimidazolidin-4-one?
The InChIKey is GBYLSCZBDXVCGI-GOSHVCBVSA-N. The full InChI is InChI=1S/C26H40N4O3S.C25H36ClN5O2.C24H26Cl2N4O2.C19H19Cl2N3O.C14H15N3OS/c1-30-24(31)26(28-25(30)27,16-15-20-9-4-2-5-10-20)18-22-13-8-14-23(17-22)29-34(32,33)19-21-11-6-3-7-12-21;1-31-23(33)25(30-24(31)27,12-10-17-6-3-2-4-7-17)16-18-8-5-9-20(14-18)29-22(32)19-11-13-28-21(26)15-19;1-15(31)29-8-6-16(7-9-29)14-30-22(32)24(2,28-23(30)27)19-5-3-4-17(10-19)18-11-20(25)13-21(26)12-18;1-24-17(25)19(13-5-6-13,23-18(24)22)14-4-2-3-11(7-14)12-8-15(20)10-16(21)9-12;1-14(8-12(18)17(2)13(15)16-14)10-3-4-11-9(7-10)5-6-19-11/h3,6-7,11-12,20,22-23,29H,2,4-5,8-10,13-19H2,1H3,(H2,27,28);11,13,15,17-18,20H,2-10,12,14,16H2,1H3,(H2,27,30)(H,29,32);3-5,10-13,16H,6-9,14H2,1-2H3,(H2,27,28);2-4,7-10,13,18,23H,5-6,22H2,1H3;3-7H,8H2,1-2H3,(H2,15,16)/t22-,23+,26+;18-,20+,25+;;;14-/m00..0/s1.
What are the key properties of 3-[(1-acetylpiperidin-4-yl)methyl]-2-amino-5-[3-(3,5-dichlorophenyl)phenyl]-5-methylimidazol-4-one;(6S)-2-amino-6-(1-benzothiophen-5-yl)-3,6-dimethyl-5H-pyrimidin-4-one;N-[(1R,3S)-3-[[(4R)-2-amino-4-(2-cyclohexylethyl)-1-methyl-5-oxoimidazol-4-yl]methyl]cyclohexyl]-2-chloropyridine-4-carboxamide;N-[(1R,3S)-3-[[(4R)-2-amino-4-(2-cyclohexylethyl)-1-methyl-5-oxoimidazol-4-yl]methyl]cyclohexyl]-1-phenylmethanesulfonamide;2-amino-5-cyclopropyl-5-[3-(3,5-dichlorophenyl)phenyl]-3-methylimidazolidin-4-one?
3-[(1-acetylpiperidin-4-yl)methyl]-2-amino-5-[3-(3,5-dichlorophenyl)phenyl]-5-methylimidazol-4-one;(6S)-2-amino-6-(1-benzothiophen-5-yl)-3,6-dimethyl-5H-pyrimidin-4-one;N-[(1R,3S)-3-[[(4R)-2-amino-4-(2-cyclohexylethyl)-1-methyl-5-oxoimidazol-4-yl]methyl]cyclohexyl]-2-chloropyridine-4-carboxamide;N-[(1R,3S)-3-[[(4R)-2-amino-4-(2-cyclohexylethyl)-1-methyl-5-oxoimidazol-4-yl]methyl]cyclohexyl]-1-phenylmethanesulfonamide;2-amino-5-cyclopropyl-5-[3-(3,5-dichlorophenyl)phenyl]-3-methylimidazolidin-4-one has a molecular weight of 2085.80 g/mol, XLogP of 18.39, 24 rotatable bonds, 8 hydrogen bond donors, and 21 hydrogen bond acceptors.
Where does this data come from?
All data for 3-[(1-acetylpiperidin-4-yl)methyl]-2-amino-5-[3-(3,5-dichlorophenyl)phenyl]-5-methylimidazol-4-one;(6S)-2-amino-6-(1-benzothiophen-5-yl)-3,6-dimethyl-5H-pyrimidin-4-one;N-[(1R,3S)-3-[[(4R)-2-amino-4-(2-cyclohexylethyl)-1-methyl-5-oxoimidazol-4-yl]methyl]cyclohexyl]-2-chloropyridine-4-carboxamide;N-[(1R,3S)-3-[[(4R)-2-amino-4-(2-cyclohexylethyl)-1-methyl-5-oxoimidazol-4-yl]methyl]cyclohexyl]-1-phenylmethanesulfonamide;2-amino-5-cyclopropyl-5-[3-(3,5-dichlorophenyl)phenyl]-3-methylimidazolidin-4-one is sourced from PubChem (CID 158209963), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).